Dr. Gershwin Theophilus Blyden , MD
Internal Medicine • Miami, FL
8335 Ne 2nd Ave
Miami, FL 331383810
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Gershwin Blyden is listed in NPPES under Internal Medicine.
-
NPI assigned on May 18, 2006; this date does not establish years in practice.
-
Published CMS data list 40,846 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0131 — Injection, acetaminophen, not otherwise specified,10 mg: 10,136 service units.
- J2405 — Injection, ondansetron hydrochloride, per 1 mg: 5,056 service units.
- 96375 — Injection of additional new drug or substance into vein: 5,032 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 28 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,435 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Oxycodone Hcl — 301 prescription fills, including refills.
- Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) — 111 prescription fills, including refills.
- Cyclobenzaprine Hcl — 89 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 65 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Miami, FL (2024, 360 clinicians with data). Median for this group: 295. Middle half: 112 to 614.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,815 clinicians with data). Median for this group: 687. Middle half: 277 to 1,489.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 14,307 in 2020 to 40,846 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
8335 Ne 2nd Ave
Miami, FL 331383810
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Hollywood, FL; Miami, FL. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Foundation For Sickle Cell Disease Research. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Yale University School Of Medicine
1979
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
82 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $486,314 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $386,780 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,706 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,577,008 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,264.52 across 21 records.
By nature of payment
- Long term medical supply or device loan: $916.63 across 11 records.
- Food and Beverage: $194.91 across 8 records.
- Education: $152.98 across 2 records.
Reporting-company totals (3 largest of 5)
- Novartis Pharmaceuticals Corporation: $991.08 across 14 records.
- Janssen Pharmaceuticals, Inc: $138.89 across 4 records.
- Pfizer Inc.: $74.99 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
47 years (graduated 1979)
CMS Doctors and Clinicians data list 1979 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Blyden has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Blyden as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Miami, FL (2024, 360 clinicians with data). Median for this group: 295. Middle half: 112 to 614.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,815 clinicians with data). Median for this group: 687. Middle half: 277 to 1,489.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Miami, FL (2024, 360 clinicians with data). Median for this group: $29,846. Middle half: $12,418 to $64,331.
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,815 clinicians with data). Median for this group: $68,256. Middle half: $27,620 to $138,398.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Miami, FL (2024, 360 clinicians with data). Median for this group: $23,440. Middle half: $9,409 to $50,403.
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Florida (2024, 5,815 clinicians with data). Median for this group: $52,728. Middle half: $20,807 to $107,475.
Medicare Part D prescriptions
More Part D prescriptions than 60% of clinicians listed under Internal Medicine in Miami, FL (2024, 449 clinicians with data). Median for this group: 1,329. Middle half: 148 to 5,867.
Close to the middle for clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: 1,318. Middle half: 158 to 5,882.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Miami, FL (2024, 449 clinicians with data). Median for this group: $82,482. Middle half: $7,967 to $424,773.
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: $86,865. Middle half: $8,159 to $434,445.
763 active clinicians are listed under Internal Medicine with a practice address in Miami, FL (10,165 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
18.3% of these 763 clinicians have the CMS telehealth indicator.
61.1% of these 763 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 185% from 14,307 in 2020 to 40,846 in 2024.
- 2020: 14,307
- 2021: 11,357
- 2022: 11,348
- 2023: 43,385
- 2024: 40,846
-
Medicare-allowed amount
Medicare-allowed amount increased 118% from $223,204 in 2020 to $486,314 in 2024.
- 2020: $223,204
- 2021: $211,444
- 2022: $185,694
- 2023: $536,143
- 2024: $486,314
-
Paid by Medicare
Paid by Medicare increased 120% from $175,429 in 2020 to $386,780 in 2024.
- 2020: $175,429
- 2021: $164,531
- 2022: $143,458
- 2023: $423,595
- 2024: $386,780
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 18% from 2,960 in 2020 to 2,435 in 2024.
- 2020: 2,960
- 2021: 2,698
- 2022: 2,630
- 2023: 2,717
- 2024: 2,435
-
30-day fills
30-day fills decreased 21% from 4,683 in 2020 to 3,706 in 2024.
- 2020: 4,683
- 2021: 4,247
- 2022: 4,000
- 2023: 3,925
- 2024: 3,706
-
Part D drug cost
Part D drug cost decreased 31% from $2,301,816 in 2020 to $1,577,008 in 2024.
- 2020: $2,301,816
- 2021: $2,024,574
- 2022: $1,971,366
- 2023: $1,938,117
- 2024: $1,577,008
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $271.51 in 2021 to $1,264.52 in 2025.
- 2021: $271.51
- 2022: $2,833.75
- 2023: $1,373.67
- 2024: $3,417.82
- 2025: $1,264.52
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 21 records totaling $1,264.52.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Novartis Pharmaceuticals Corporation |
Long term medical supply or device loan
In-kind items and services
|
KISQALI | General | $83.33 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
ERLEADA | General | $77.99 |
| Pfizer Inc. |
Education
In-kind items and services
|
— | General | $74.99 |
| Verity Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
Trelstar | General | $34.97 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $29.92 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $26.63 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
CALQUENCE | General | $24.59 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $23.71 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $21.80 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $17.90 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $15.39 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0131
Injection, acetaminophen, not otherwise specified,10 mg
|
10,136 | 21 | $0.84 | $0.05 |
|
J2405
Injection, ondansetron hydrochloride, per 1 mg
|
5,056 | 28 | $2.86 | $0.09 |
|
96375
Injection of additional new drug or substance into vein
|
5,032 | 29 | $48.05 | $15.24 |
|
96361
Infusion into a vein for hydration, each additional hour
|
1,984 | 29 | $32.12 | $12.28 |
|
J1170
Injection, hydromorphone, up to 4 mg
|
1,983 | 24 | $4.53 | $3.84 |
|
J1200
Injection, diphenhydramine hcl, up to 50 mg
|
1,935 | 29 | $3.89 | $0.82 |
|
J1885
Injection, ketorolac tromethamine, per 15 mg
|
1,530 | 24 | $8.69 | $0.62 |
|
J1171
Injection, hydromorphone, 0.1 mg
|
1,510 | 13 | $0.42 | $0.08 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,386 | 79 | $249.07 | $129.71 |
|
81003
Automated urinalysis test
|
1,346 | 34 | $2.86 | $2.17 |
|
96374
Injection of drug or substance into vein
|
1,335 | 29 | $121.92 | $36.29 |
|
85018
Blood count, hemoglobin
|
1,182 | 32 | $5.00 | $2.32 |
|
82962
Blood glucose (sugar) test performed by hand-held instrument
|
1,148 | 33 | $7.20 | $3.20 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
965 | 33 | $36.16 | $14.49 |
|
J7060
5% dextrose/water (500 ml = 1 unit)
|
913 | 25 | $4.00 | $1.78 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
865 | 32 | $13.72 | $7.05 |
|
81025
Urine pregnancy test
|
675 | 21 | $17.89 | $8.41 |
|
J7040
Infusion, normal saline solution, sterile (500 ml = 1 unit)
|
534 | 26 | $3.00 | $1.32 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
384 | 21 | $371.00 | $182.93 |
|
J2270
Injection, morphine sulfate, up to 10 mg
|
334 | 13 | $6.28 | $4.12 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
225 | 21 | $132.00 | $62.31 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
212 | 22 | $153.86 | $90.40 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
70 | 24 | $20.00 | $16.51 |
|
96127
Assessment of emotional or behavioral problems
|
54 | 19 | $11.00 | $4.83 |
|
36415
Insertion of needle into vein for collection of blood sample
|
14 | 12 | $20.79 | $8.65 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Oxycodone Hcl | Oxycodone Hcl | 301 | 8,343 | $13,682.92 | 36 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 111 | 2,737 | $4,748.97 | 22 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 89 | 2,625 | $727.85 | 26 |
| Morphine Sulfate Er | Morphine Sulfate | 82 | 2,490 | $6,316.67 | 16 |
| Hydroxyurea | Hydroxyurea | 79 | 3,537 | $3,018.60 | 21 |
| Gabapentin | Gabapentin | 78 | 3,020 | $786.32 | 25 |
| Temazepam | Temazepam | 71 | 2,130 | $747.48 | — |
| Oxycontin | Oxycodone Hcl | 68 | 2,006 | $129,093.63 | — |
| Prednisone | Prednisone | 65 | 1,872 | $246.14 | 13 |
| Atorvastatin Calcium | Atorvastatin Calcium | 61 | 5,131 | $407.73 | 20 |
| Abiraterone Acetate | Abiraterone Acetate | 58 | 1,740 | $110,529.47 | — |
| Amlodipine Besylate | Amlodipine Besylate | 57 | 5,028 | $174.86 | 19 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 54 | 3,004 | $530.14 | 15 |
| Nifedipine Er | Nifedipine | 47 | 3,540 | $729.90 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 43 | 3,150 | $99.77 | — |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | 1,350 | $261.27 | — |
| Methadone Hcl | Methadone Hcl | 41 | 1,223 | $838.86 | — |
| Adakveo | Crizanlizumab-Tmca | 40 | 1,106 | $446,794.09 | — |
| Imatinib Mesylate | Imatinib Mesylate | 39 | 1,170 | $7,616.69 | — |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 37 | 653 | $612.56 | — |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 35 | 2,665 | $279.04 | 13 |
| Alprazolam | Alprazolam | 34 | 1,020 | $154.79 | — |
| Omeprazole | Omeprazole | 34 | 2,610 | $522.10 | — |
| Dexamethasone | Dexamethasone | 34 | 917 | $1,136.92 | — |
| Losartan Potassium | Losartan Potassium | 33 | 2,980 | $158.04 | 11 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-01-11NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20110124000250
FL
3971792367
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Foundation For Sickle Cell Disease Research
151 Nw 11th St, Homestead, FL 330309999
Phone: 9543973251
Secondary Practice Locations
1685 S State Road 7, Unit 4
Hollywood, FL 33023
Phone: 9543973251
1394 62nd Street
Miami, FL 33147
Phone: 9543973251
Career & Practice History
NPI enumerated May 18, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Miami
- Dr. Richard Blumengold, MD
- Dr. Alejandro Novelo, MD
- Dr. Francisco Lasso-Claudio, MD
- Dr. Erica Graff, MD
- Dr. Magdalena Murman, MD
- Dr. Rogelio Zaldivar, MD
Mailing Address
8335 Ne 2nd Ave
Miami, FL 331383810
Phone: 3057570113